Director, Global Commercial, Cell Therapy, Myeloma

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”, a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Global Commercial Multiple Myeloma Director is responsible, for (1) setting the strategic vision and strategy for our MM CAR T business, including Go-to-Market and launch strategy/readiness activities for LCM opportunities for arlo-cel (first-in-class GPRC5D CAR T), and (2) providing Commercial strategy and planning for new MM assets entering late stage development.

Drive development and execution of the strategic brand plan, GTM strategy, and global launch plan for arlo-cel (first-in-class GPRC5D CART) lifecycle opportunities

Foster a collaborative, insight-driven culture of continuous learning across the global commercial community

Ownership of arlo-cel LCM activities in partnership with the rest of the MM brand team, including:

• Accountable for WW Commercial launch readiness
• Lead commercial opportunity assessments and geographic footprint expansion, integrating market insights, competitive intelligence, and pricing dynamics to formulate clear strategic options and recommendations
• Translate market insights and performance data into strategic trade-offs and actionable recommendations for senior leadership and governance forums
• Align with Commercial teams across Hematology to ensure integrated strategy and execution
• Interface with functions (e.g., GDD, Commercial, CTDO) to synthesize inputs into a cohesive cross-functional franchise-level MM CT brand plan
• Lead strategy development for new MM assets entering late development
• Lead commercial planning and execution excellence, including development of key enablement materials (campaign frameworks, messaging, competitive tools), oversight of agency management and budgets, and prioritization of congress presence and scientific engagement in partnership with cross-functional stakeholders
• Partner closely with the Global Executive Director to shape strategic recommendations and support key governance decisions on high-impact topics (e.g., indication expansion, market and site activation, timing delays, slot allocation)
• Serve as the primary global commercial partner to selected markets, ensuring strong alignment with global strategy while enabling locally relevant execution and accelerating performance through best practice sharing and cross-market insights
• Serve as the lead with support from the Multiple Myeloma Cell Therapy Lead for arlo-cel LCM/new asset positioning/corporate message development and IR messaging, pressure-testing messaging
• Act as a central point of coordination for patient advocacy and broader stakeholder engagement

• Minimum 10 years of experience in biopharma
• Bachelor’s degree required, with a life-sciences related discipline (or other scientific education) preferred
• Advanced degree preferred, including business and scientific (MBA,MD/PhD/PharmD)
• Experience launching growth brands or indication expansions in highly competitive areas, in the US and globally, with proven track record of driving performance and executional excellence
• Relevant experience in Multiple Myeloma and Cell Therapy is preferable
• Ability to operate and prioritize effectively in a dynamic, ambiguous environment
• Experience working with customers and translating…